Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment

Running, not enrolling

Conditions studied: Renal Cancer

In brief

The purpose of this study is to better understand how effective ablation is for destroying tumor cells in the kidney and whether quality of life is improved for patients. Participation in ARMOR may involve retrospective data collection only, combined retrospective and prospective data collection, or prospective data collection

Key facts

Study ID

NCT01888198

Run by

Memorial Sloan Kettering Cancer Center

People needed

294

Starts

2013-06-01

Expected to finish

2027-06-01

Last updated by the study team

2026-07-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Retrospective enrollment:
• Patients having undergone percutaneous, open or laparoscopic energy ablation of a renal mass.
• Prospective enrollment:
• Patients scheduled to undergo, rather than having undergone, percutaneous, open or laparoscopic energy ablation of a renal mass.

You may not qualify if…

• Patients not having undergone, or considered candidates for percutaneous, open or laparoscopic energy ablation of a renal mass
• Non-English speaking patients
• Patients under the age of 18.

Where it is running

• University of California, Los Angeles — Los Angeles, California, United States
• University of Maryland Medical Center — Baltimore, Maryland, United States
• Memorial Sloan Kettering Cancer Center — New York, New York, United States
• Thomas Jefferson University Hospital — Philadelphia, Pennsylvania, United States
• Rhode Island Hospital — Providence, Rhode Island, United States
• Md Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.